Cardiovascular Summit 2025 - ATTR-CM Highlights

Dr Aldostefano Porcari is a Consultant Cardiologist at the Cardiovascular Department 
(Azienda Sanitaria Universitaria Giuliano-Isontina, ASUGI), Italy, and a Research 
Fellow at University College London (UCL), UK. He recently completed a PhD in 
amyloidosis at UCL’s National Amyloidosis Centre under Prof. Julian D. Gillmore and 
Prof. Marianna Fontana. His work focuses on early diagnosis, clinical management, 
treatment and prognostic stratification of amyloidosis - particularly transthyretin (ATTR) 
cardiomyopathy. Dr Porcari has contributed to studies that have shaped contemporary 
diagnostic pathways and real-world treatment outcomes, with findings published in 
leading journals. He has authored more than 135 peer-reviewed papers (including in 
Circulation, JACC, European Heart Journal, and JAMA Cardiology) and received over 
20 research prizes, notably the Melvin Judkins Early Career Award (AHA, 2023), the 
Young Investigator Award Preventive Cardiology (ESC 2022) and Clinical Cardiology 
(ESC 2025), and the William W. Parmley Young Author Achievement Award (ACC/ 
JACC, 2025). Current interests include understanding natural history in early disease 
stages, pragmatic algorithms for stroke prevention, measuring disease-progression, 
and integrating imaging and genetics into personalised care.

Dr Dungu is a Consultant Cardiologist at the Essex Cardiothoracic Centre and Honorary Senior Clinical Lecturer at Anglia Ruskin University. He has lead the Essex Inherited 
Cardiac Conditions (ICC) service since it was established January 2023, and he was 
the first cardiologist with specialist cardiac MRI training in the Essex region.

Dr Dungu’s research interest is cardiomyopathy and he was awarded a BHF Clinical 
Research Fellowship in 2009, culminating in the award of a PhD degree in ATTR cardiac amyloidosis. The research project produced several papers and over 30 abstracts. 
He has presented at major international cardiology conferences in Europe and North 
America, and co-authored publications in the top 3 medical journals NEJM, Lancet and JAMA.

Prof Dr med Carsten Tschöpe is a distinguished cardiologist and researcher, leading the 
Clinical Cardiomyopathy Unit at the Deutsches Herzzentrum der Charité (DHZC) and 
the Translational Cardiovascular Unit at the Berlin Institute of Health (BIH) and BCRT. 
As a University Professor of Medicine and Cardiology, his expertise spans intensive 
and interventional cardiology, with a prominent focus on heart failure, myocarditis, 
and cardiomyopathies. With over 550 publications, he has made a lasting impact on 
immunocardiology. As a board member of the Heart Failure Association (HFA) and 
Chair of the ESC Working Group on Myocardial and Pericardial Diseases, he plays a 
pivotal role in shaping the future of cardiovascular research and treatment.